Cooper Companies (The) (COO): are the analysts right?

Cooper Companies (The) · Health Care · ref. ETF XLV · 50 calls · price $71.89
What the company does: Cooper Companies fabrique et commercialise des lentilles de contact et produits chirurgicaux ophtalmologiques.
📈 1-year price
$71.89-3.2% over range
Jul 8, 25low $58.98 · high $84.32Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
70% recommend buying · 10 analysts

🎯 Analyst price target on COO

High target · 1 analyst$103+43.3%
Median target · 10 analysts$85+18.2%
Low target · 1 analyst$66-8.2%
Current price$71.89

🗳️ The analyst consensus

Analyst breakdown · 10 (6 months)
Strong Buy0%
Buy70%
Hold30%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on COO

Most reliable analysts on COO (% profitable · 365j · ≥2 calls)
Piper Sandler 0% -7.6% 2
Baird 0% -10.5% 2
Citigroup 0% -16.1% 2

📊 What $1,000 invested in Cooper Companies (The) would be worth

In short — $1,000 invested in Cooper Companies (The) 10 years ago would be worth $2,137 today, i.e. +8%/yr on average. Best year: 2016 (+30%), worst: 2022 (-21%). Price performance, excluding dividends.

If I'd invested $1,000 in Cooper Companies (The)

InvestmentWorth todayGain
1 years ago$780-22%
3 years ago$867-13%
5 years ago$789-21%
10 years ago$2,137+114%
since inception (1983)$8,546+755%

Return by year (Cooper Companies (The))

YearReturn$1,000 invested at year start
2026 (YTD)-13%$875 (-13%)
2025-11%$780 (-22%)
2024-3%$758 (-24%)
2023+14%$867 (-13%)
2022-21%$685 (-32%)
2021+15%$789 (-21%)
2020+13%$893 (-11%)
2019+26%$1,127 (+13%)
2018+17%$1,317 (+32%)
2017+25%$1,640 (+64%)
2016+30%$2,137 (+114%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on COO

BNP Paribas
Jun 8, 26
▲ Outperform · 🎯$92
Price at call : $68.62 — upside +34%
Today : $71.89 — upside +28%
🎯 on COO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 8, 27
JP Morgan
Jun 5, 26
■ Neutral neutral · not a buy · 🎯$71
Price at call : $66.79 — gap to target +6%
Today : $71.89 — gap to target -1%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Jun 5, 27
Stifel
Jun 5, 26
▲ Buy · 🎯$85
Price at call : $66.79 — upside +27%
Today : $71.89 — upside +18%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jun 5, 27
Wells Fargo
Jun 5, 26
■ Equal-Weight neutral · not a buy · 🎯$66
Price at call : $66.79 — gap to target -1%
Today : $71.89 — gap to target -8%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jun 5, 27
Needham
Jun 5, 26
▲ Buy · 🎯$86
Price at call : $67.34 — upside +28%
Today : $71.89 — upside +20%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Jun 5, 27
Baird
Jun 5, 26
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $71.89 — upside +18%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jun 5, 27
Mizuho
Jun 4, 26
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $71.89 — upside +18%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Jun 4, 27
▲ Overweight · 🎯$86
Price at call : $59.49 — upside +45%
Today : $71.89 — upside +20%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 1, 27
Citigroup
May 28, 26
■ Neutral neutral · not a buy · 🎯$69
Price at call : $61.21 — gap to target +13%
Today : $71.89 — gap to target -4%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 28, 27
Citigroup
Mar 6, 26
■ Neutral neutral · not a buy · 🎯$87
Price at call : $75.82 — gap to target +15%
Today : $71.89 — gap to target +21%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 6, 27
Barclays
Mar 6, 26
▲ Overweight · 🎯$103
Price at call : $75.82 — upside +36%
Today : $71.89 — upside +43%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Mar 6, 27
Needham
Mar 6, 26
▲ Buy · 🎯$101
Price at call : $76.55 — upside +32%
Today : $71.89 — upside +40%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Mar 6, 27
Needham
Feb 3, 26
▲ Buy · 🎯$99
Price at call : $79.33 — upside +25%
Today : $71.89 — upside +38%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Feb 3, 27
Barclays
Jan 26, 26
▲ Overweight · 🎯$98
Price at call : $80.7 — upside +21%
Today : $71.89 — upside +36%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jan 26, 27
Citigroup
Dec 8, 25
■ Neutral neutral · not a buy · 🎯$88
Price at call : $78.51 — gap to target +12%
Today : $71.89 — gap to target +22%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Dec 8, 26
■ Equal-Weight neutral · not a buy · 🎯$83
Price at call : $78.51 — gap to target +6%
Today : $71.89 — gap to target +15%
🎯 on COO : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 8, 26
▼ Sell · 🎯$71
Price at call : $78.51 — upside -10%
Today : $71.89 — upside -1%
🎯 on COO : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Dec 8, 26
Stifel
Dec 5, 25
▲ Buy · 🎯$95
Price at call : $78.04 — upside +22%
Today : $71.89 — upside +32%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Dec 5, 26
▲ Overweight · 🎯$94
Price at call : $78.04 — upside +20%
Today : $71.89 — upside +31%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Dec 5, 26
Wells Fargo
Dec 5, 25
■ Equal-Weight neutral · not a buy · 🎯$82
Price at call : $78.04 — gap to target +5%
Today : $71.89 — gap to target +14%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 5, 26
JP Morgan
Dec 5, 25
■ Neutral neutral · not a buy · 🎯$78
Price at call : $78.04 — gap to target -0%
Today : $71.89 — gap to target +8%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Dec 5, 26
Mizuho
Dec 5, 25
▲ Outperform · 🎯$100
Price at call : $81.4 — upside +23%
Today : $71.89 — upside +39%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Dec 5, 26
Baird
Dec 5, 25
▲ Outperform · 🎯$98
Price at call : $81.4 — upside +20%
Today : $71.89 — upside +36%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Dec 5, 26
Needham
Dec 5, 25
▲ Buy · 🎯$100
Price at call : $81.4 — upside +23%
Today : $71.89 — upside +39%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Dec 5, 26
Wells Fargo
Nov 13, 25
■ Equal-Weight neutral · not a buy · 🎯$72
Price at call : $71.75 — gap to target +0%
Today : $71.89 — gap to target +0%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Nov 13, 26
Barclays
Oct 13, 25
▲ Overweight · 🎯$85
Price at call : $69.3 — upside +23%
Today : $71.89 — upside +18%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 13, 26
▼ Sell · 🎯$64
Price at call : $69.12 — upside -7%
Today : $71.89 — upside -11%
🎯 on COO : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 1, 26
JP Morgan
Aug 28, 25
■ Neutral neutral · not a buy · 🎯$66
Price at call : $67.4 — gap to target -2%
Today : $71.89 — gap to target -8%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Aug 28, 26
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $67.4 — gap to target +13%
Today : $71.89 — gap to target +6%
🎯 on COO : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 28, 26
Baird
Aug 28, 25
▲ Outperform · 🎯$85
Price at call : $67.4 — upside +26%
Today : $71.89 — upside +18%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Aug 28, 26
Wells Fargo
Aug 28, 25
▲ Overweight · 🎯$72
Price at call : $67.4 — upside +7%
Today : $71.89 — upside +0%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 28, 26
Piper Sandler
Aug 28, 25
▲ Overweight · 🎯$83
Price at call : $67.4 — upside +23%
Today : $71.89 — upside +15%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Aug 28, 26
Stifel
Aug 28, 25
▲ Buy · 🎯$85
Price at call : $64.58 — upside +32%
Today : $71.89 — upside +18%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Aug 28, 26
Citigroup
Aug 28, 25
■ Neutral neutral · not a buy · 🎯$72
Price at call : $64.58 — gap to target +11%
Today : $71.89 — gap to target +0%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Aug 28, 26
Needham
Aug 28, 25
▲ Buy · 🎯$94
Price at call : $64.58 — upside +46%
Today : $71.89 — upside +31%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Aug 28, 26
Mizuho
Jul 16, 25
▲ Outperform · 🎯$90
Price at call : $72.7 — upside +24%
Today : $71.89 — upside +25%
🎯 on COO : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Jul 16, 26
Needham
Jun 17, 25
▲ Buy · 🎯$94
Price at call : $68.76 — upside +37%
Today : $71.89 — upside +31%
Expected +37% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
-5.4%
stock -5% · XLV +13%
Baird
May 30, 25
▲ Outperform · 🎯$97
Price at call : $67 — upside +45%
Today : $71.89 — upside +35%
Expected +45% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-10.2%
stock -10% · XLV +11%
Piper Sandler
May 30, 25
▲ Overweight · 🎯$105
Price at call : $67 — upside +57%
Today : $71.89 — upside +46%
Expected +57% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-10.2%
stock -10% · XLV +11%
Wells Fargo
May 30, 25
▲ Overweight · 🎯$93
Price at call : $67 — upside +39%
Today : $71.89 — upside +29%
Expected +39% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
-10.2%
stock -10% · XLV +11%
JP Morgan
May 30, 25
■ Neutral neutral · not a buy · 🎯$76
Price at call : $68.28 — gap to target +11%
Today : $71.89 — gap to target +6%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : May 30, 26
Needham
May 30, 25
■ Hold neutral · not a buy
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : May 30, 26
Needham
May 22, 25
■ Hold neutral · not a buy
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : May 22, 26
Stifel
Mar 7, 25
▲ Buy · 🎯$105
Price at call : $79.89 — upside +31%
Today : $71.89 — upside +46%
Expected +31% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.2% (297 calls)
-5.1%
stock -5% · XLV +4%
JP Morgan
Mar 7, 25
▲ Overweight · 🎯$110
Price at call : $79.89 — upside +38%
Today : $71.89 — upside +53%
Expected +38% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
-5.1%
stock -5% · XLV +4%
▲ Overweight · 🎯$115
Price at call : $79.89 — upside +44%
Today : $71.89 — upside +60%
Expected +44% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-5.1%
stock -5% · XLV +4%
Citigroup
Mar 7, 25
▲ Buy · 🎯$110
Price at call : $85 — upside +29%
Today : $71.89 — upside +53%
Expected +29% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
-10.8%
stock -11% · XLV +3%
Baird
Mar 7, 25
▲ Outperform · 🎯$107
Price at call : $85 — upside +26%
Today : $71.89 — upside +49%
Expected +26% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-10.8%
stock -11% · XLV +3%
Needham
Mar 7, 25
■ Hold neutral · not a buy
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Mar 7, 26
Citigroup
Dec 6, 24
▲ Buy · 🎯$115
Price at call : $99.26 — upside +16%
Today : $71.89 — upside +60%
Expected +16% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
-21.4%
stock -21% · XLV +5%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)